Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03YZJ
|
||||
Former ID |
DIB004033
|
||||
Drug Name |
ALO-02 Oxycodone- naltrexone core
|
||||
Synonyms |
ALO-02 Oxycodone-naltrexone core
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Phase 3 | [551491] | ||
Company |
Elite Pharmaceuticals; pfizer
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
[C@]123[C@@]4([C@@H](Cc5c1c(O[C@H]2C(=O)CC4)c(cc5)OC)N(<br />CC3)C)O.[C@]123[C@@]4([C@H](N(CC5CC5)CC3)Cc3c1c(O[C@H]2<br />C(=O)CC4)c(cc3)O)O
|
||||
Target and Pathway | |||||
Target(s) | Opioid receptor | Target Info | Modulator | [527586] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.